Bluejay Diagnostics Stock Performance
| BJDX Stock | USD 0.76 0.03 3.80% |
The firm shows a Beta (market volatility) of 1.38, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bluejay Diagnostics will likely underperform. At this point, Bluejay Diagnostics has a negative expected return of -1.61%. Please make sure to confirm Bluejay Diagnostics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Bluejay Diagnostics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:50 | Last Split Date 2024-11-18 |
1 | Will Bluejay Diagnostics Inc. stock maintain momentum in 2025 - Long Setup Fast ExitEntry Strategy Plans - newser.com | 10/30/2025 |
2 | Acquisition by Chase Donald R of 25000 shares of Bluejay Diagnostics at 2.79 subject to Rule 16b-3 | 11/05/2025 |
3 | Bluejay Diagnostics Corporate Update Advancing Clinical Milestones and Strategic Partnerships | 11/10/2025 |
4 | Why Bluejay Diagnostics Inc. stock could outperform in 2025 - Weekly Risk Summary Reliable Intraday Trade Alerts - newser.com | 11/18/2025 |
5 | Can Bluejay Diagnostics Inc. stock hit record highs again - Weekly Market Report Entry Point Strategy Guides - ulpravda.ru | 12/19/2025 |
6 | Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production | 12/29/2025 |
7 | Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split | 01/27/2026 |
| Begin Period Cash Flow | 2.2 M | |
| Total Cashflows From Investing Activities | -306.8 K |
Bluejay Diagnostics Relative Risk vs. Return Landscape
If you would invest 220.00 in Bluejay Diagnostics on October 30, 2025 and sell it today you would lose (144.00) from holding Bluejay Diagnostics or give up 65.45% of portfolio value over 90 days. Bluejay Diagnostics is currently does not generate positive expected returns and assumes 5.6347% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than Bluejay, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bluejay Diagnostics Target Price Odds to finish over Current Price
The tendency of Bluejay Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.76 | 90 days | 0.76 | about 80.21 |
Based on a normal probability distribution, the odds of Bluejay Diagnostics to move above the current price in 90 days from now is about 80.21 (This Bluejay Diagnostics probability density function shows the probability of Bluejay Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.38 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bluejay Diagnostics will likely underperform. Additionally Bluejay Diagnostics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Bluejay Diagnostics Price Density |
| Price |
Predictive Modules for Bluejay Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bluejay Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluejay Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluejay Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bluejay Diagnostics is not an exception. The market had few large corrections towards the Bluejay Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bluejay Diagnostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bluejay Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.72 | |
β | Beta against Dow Jones | 1.38 | |
σ | Overall volatility | 0.53 | |
Ir | Information ratio | -0.31 |
Bluejay Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bluejay Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bluejay Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bluejay Diagnostics generated a negative expected return over the last 90 days | |
| Bluejay Diagnostics has high historical volatility and very poor performance | |
| Bluejay Diagnostics has some characteristics of a very speculative penny stock | |
| Bluejay Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.72 M) with profit before overhead, payroll, taxes, and interest of 48.91 K. | |
| Bluejay Diagnostics currently holds about 15.34 M in cash with (7.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Latest headline from finance.yahoo.com: Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office |
Bluejay Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bluejay Stock often depends not only on the future outlook of the current and potential Bluejay Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bluejay Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 183.4 K | |
| Cash And Short Term Investments | 4.3 M |
Bluejay Diagnostics Fundamentals Growth
Bluejay Stock prices reflect investors' perceptions of the future prospects and financial health of Bluejay Diagnostics, and Bluejay Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bluejay Stock performance.
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.66 | ||||
| Current Valuation | (1.5 M) | ||||
| Shares Outstanding | 1.81 M | ||||
| Price To Book | 0.40 X | ||||
| Price To Sales | 54.99 X | ||||
| Gross Profit | 48.91 K | ||||
| EBITDA | (6.7 M) | ||||
| Net Income | (7.72 M) | ||||
| Cash And Equivalents | 15.34 M | ||||
| Cash Per Share | 0.76 X | ||||
| Total Debt | 222.25 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 17.41 X | ||||
| Book Value Per Share | 2.25 X | ||||
| Cash Flow From Operations | (7.82 M) | ||||
| Earnings Per Share | 164.37 X | ||||
| Market Capitalization | 1.43 M | ||||
| Total Asset | 6.66 M | ||||
| Retained Earnings | (34.67 M) | ||||
| Working Capital | 4.09 M | ||||
About Bluejay Diagnostics Performance
Evaluating Bluejay Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Bluejay Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bluejay Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 226.56 | 281.78 | |
| Return On Tangible Assets | (1.33) | (1.40) | |
| Return On Capital Employed | (1.41) | (1.48) | |
| Return On Assets | (1.33) | (1.40) | |
| Return On Equity | (1.55) | (1.63) |
Things to note about Bluejay Diagnostics performance evaluation
Checking the ongoing alerts about Bluejay Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bluejay Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bluejay Diagnostics generated a negative expected return over the last 90 days | |
| Bluejay Diagnostics has high historical volatility and very poor performance | |
| Bluejay Diagnostics has some characteristics of a very speculative penny stock | |
| Bluejay Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.72 M) with profit before overhead, payroll, taxes, and interest of 48.91 K. | |
| Bluejay Diagnostics currently holds about 15.34 M in cash with (7.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Latest headline from finance.yahoo.com: Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office |
- Analyzing Bluejay Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bluejay Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Bluejay Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bluejay Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bluejay Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bluejay Diagnostics' stock. These opinions can provide insight into Bluejay Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bluejay Stock Analysis
When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.